🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchOrforglipron ATTAIN-4 — cardiovascular outcomes arm Page 4

Orforglipron ATTAIN-4 — cardiovascular outcomes arm

TrialTracker_MD Fri, Feb 27, 2026 at 7:53 AM 21 replies 544 viewsPage 4 of 5
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Feb 27, 2026 at 1:33 PM#16

Just wanted to say — for anyone reading this Orforglipron thread who is feeling discouraged: it gets better. The first 6 weeks are the hardest. Hang in there. 💪

Last edited: Feb 27, 2026 at 3:33 PM
8 20LipidDoc_ATL, BariatricNurseD, MASHdoc_SA and 5 others
Reply Quote Save Share Report
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
Feb 27, 2026 at 1:50 PM#17

As a pharmacist, I want to add some clinical context to this discussion on Orforglipron ATTAIN-4 cardiovascular.

Building on what NicoleRaleigh said — the evidence base here is robust. The key publications to reference are from the SUSTAIN program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Feb 27, 2026 at 5:50 PM
40 14GenomicsKate, Dr.ObesityMed, HealthEcon_DC and 37 others
Reply Quote Save Share Report
mike.trainer_LA
Senior Member
1,567
7,234
Apr 2024
Los Angeles, CA
Feb 27, 2026 at 2:07 PM#18
Dr.DermMIA said:
The first 6 weeks are the hardest

Gonna push back on this one. Orforglipron ATTAIN-4 is not that straightforward in my experience. I have been on this for 12 months and the reality is messier than the trials suggest.

Don't get me wrong — the medication works. But cost accessibility is a real barrier. We should be honest about that.

Last edited: Feb 27, 2026 at 6:07 PM
33 23mia_MS2, LeilaHI, marcus_mpls and 30 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Feb 27, 2026 at 2:24 PM#19

Subscribing to this thread. Orforglipron ATTAIN-4 is exactly what I've been researching. 🙏

44 1sophie_paris, mel_PDX, Dr.AddMedPHL and 41 others
Reply Quote Save Share Report
LarryQC_SD
Senior Member
2,123
9,876
Jan 2024
San Diego, CA
Feb 27, 2026 at 2:41 PM#20

Reading this thread on Orforglipron ATTAIN-4 hits close to home. Night shift nurse — I started at 275 lbs and felt like I would tried everything.

11 months on tirz and I am a different person. Not just the 50 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Orforglipron — take the leap. It was the best health decision I have ever made. ❤️

43 4dan_philly, MeganSA_TX, LarryQC_SD and 40 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register